Lortab and Isosorbide mononitrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lortab (acetaminophen; hydrocodone bitartrate) and Isosorbide mononitrate (isosorbide mononitrate). Common drug interactions include alopecia among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Lortab and Isosorbide mononitrate. It is created by eHealthMe based on reports of 86 people who take the same drugs from the FDA, and is updated regularly.

What is Lortab?

Lortab has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 31,285 Lortab users. Check the latest studies of Lortab.

What is Isosorbide mononitrate?

Isosorbide mononitrate has active ingredients of isosorbide mononitrate. It is often used in angina. eHealthMe is studying from 26,858 Isosorbide mononitrate users. Check the latest studies of Isosorbide mononitrate.



On Jul, 20, 2026

86 people who take Lortab and Isosorbide mononitrate together, and have interactions are studied.

Lortab and Isosorbide mononitrate drug interactions.

What are the common drug interactions of Lortab and Isosorbide Mononitrate, by gender? *:

female:

  1. Alopecia (absence of hair from areas of the body)
  2. Ankle fracture
  3. Anxiety
  4. Diarrhoea
  5. Emotional distress
  6. Headache (pain in head)
  7. Humerus fracture (injury to the upper arm bone)
  8. Limb crushing injury (crushing injury of upper limb)
  9. Lower limb fracture
  10. Muscle spasms (muscle contraction)

male:

  1. Renal failure (kidney dysfunction)
  2. Pneumonia
  3. Subdural haematoma (blood collects between the skull and the surface of the brain)
  4. Renal failure chronic (long lasting kidney dysfunction)
  5. Gastrointestinal perforation (hole in the digestive tract)
  6. Anaemia (lack of blood)
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  8. Dementia (madness)
  9. Febrile neutropenia (fever with reduced white blood cells)
  10. General physical health deterioration (weak health status)

What are the common drug interactions of Lortab and Isosorbide Mononitrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Renal failure (kidney dysfunction)
  2. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  3. Abdominal pain
  4. Agitation (state of anxiety or nervous excitement)
  5. Chest pain
  6. Decreased appetite
  7. Diarrhoea
  8. Dizziness
  9. Hypotension (abnormally low blood pressure)
  10. Nausea (feeling of having an urge to vomit)

50-59:

  1. Humerus fracture (injury to the upper arm bone)
  2. Limb crushing injury (crushing injury of upper limb)
  3. Lower limb fracture
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Osteoporosis (bones weak and more likely to break)
  6. Radius fracture
  7. Scar
  8. Upper limb fracture
  9. Anxiety
  10. Depression

60+:

  1. Pneumonia
  2. Chronic kidney disease
  3. Hypotension (abnormally low blood pressure)
  4. Renal failure (kidney dysfunction)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Dementia (madness)
  8. Febrile neutropenia (fever with reduced white blood cells)
  9. General physical health deterioration (weak health status)
  10. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

What are the existing conditions these people have? *

  1. High Blood Pressure: 17 people, 19.77%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 16 people, 18.60%
  3. Chest Pain: 8 people, 9.30%
  4. High Blood Cholesterol: 8 people, 9.30%
  5. Rashes (redness): 7 people, 8.14%
  6. Constipation: 7 people, 8.14%
  7. Depression: 7 people, 8.14%
  8. Febrile Neutropenia (fever with reduced white blood cells): 6 people, 6.98%
  9. Cardiac Disorder: 6 people, 6.98%
  10. Thrombocytopenia (decrease of platelets in blood): 6 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Lortab and Isosorbide mononitrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lortab and Isosorbide mononitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lortab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Isosorbide mononitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lortab and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isosorbide mononitrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; hydrocodone bitartrate and isosorbide mononitrate (the active ingredients of Lortab and Isosorbide mononitrate, respectively), and Lortab and Isosorbide mononitrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: